FirstWord

The agency is seeking input from the public on risk assessment, premarket evaluation and postmarket monitoring for the "transformative" devices.

The virtual cell world model is the first AI system to integrate the entire molecular-to-cellular spectrum into one continuous simulation.

The expanded offering comes as the company gears up for an initial public offering within the next 18 months.

UPMC says over 60% of its Abridge users adopted the agent largely on their own, with decision support "embedded in the workflow, not adjacent."

MONARCH QUEST 3 is designed to help physicians keep track of lung nodules if anatomy shifts between pre-procedure scans and the lung biopsy.

DALLAS, Aug. 18, 2026 — Despite rapid advances in digital health, artificial intelligence and remote patient monitoring, many promising health technologies still fail to reach patients who need them m...

First randomized controlled trial of an at-home, noninvasive BCI therapy for chronic stroke shows more than half of patients achieved clinically meaningful recoveryVAN NUYS, Calif., Aug. 18, 2026 /PRN...

Following a decade of exploration from the 2014 NVIDIA GTC to the PreciousGPT model series, Insilico Medicine presents the industry's first multi-agent Virtual Aging Cell (VAC) platform with biologica...

SAN FRANCISCO--(BUSINESS WIRE)-- Astro Health Inc., a San Francisco-based artificial intelligence digital health company, today announced that its first peer-reviewed research from its clinical study ...

12 Aug 2026Experts' discussions during the ESMO Gastrointestinal Cancers Congress 2026 explored how AI is moving beyond image recognition to support surgery, pathology and image-guided intervention.Th...